Prosecution Insights
Last updated: July 17, 2026
Application No. 19/268,875

MEASURING AND VERIFYING DRUG PORTIONS

Non-Final OA §112§DP
Filed
Jul 14, 2025
Priority
Jul 19, 2019 — continuation of 11/195,270 +2 more
Examiner
BRUMFIELD, SHANIKA M
Art Unit
Tech Center
Assignee
Becton Dickinson Rowa Germany GmbH
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
1y 9m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
270 granted / 393 resolved
+8.7% vs TC avg
Moderate +14% lift
Without
With
+14.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
25 currently pending
Career history
416
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
84.3%
+44.3% vs TC avg
§102
8.1%
-31.9% vs TC avg
§112
0.8%
-39.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 393 resolved cases

Office Action

§112 §DP
CTNF 19/268,875 CTNF 89353 DETAILED ACTION Notice of Pre-AIA or AIA Status 07-03-aia AIA 15-10-aia The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA. Claim Rejections - 35 USC § 112 07-30-02 AIA The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. 07-34-01 Claims 1- 12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. 07-34-05 AIA Claim 1 recites the limitation " the calibrated measuring camera " in lines 4 - 5 . There is insufficient antecedent basis for this limitation in the claim. Claim 10 recites the limitation “calibrating a measuring camera” in line 1. Claim 1, the claim upon which claim 10 properly depends, however, recites the limitation “the calibrated measuring camera” in lines 4 – 5. It is unclear whether the calibrated measuring camera of claim 10 is the same calibrated measuring camera recited in claim 1 or whether the calibrated measuring camera of claim 10 is intended to be a separate camera. Claims 2 – 12 properly depend on claim 1 and are therefore likewise rejected. Double Patenting 08-33 AIA The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg , 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman , 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi , 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum , 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel , 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington , 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA. A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA/25, or PTO/AIA/26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. 08-34 AIA Claim s 1, 3 – 13, 15, and 17 – 19 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim s 1 – 4, 6, 10 – 13, 15, and 16 of U.S. Patent No. 11,195,270 . Although the claims at issue are not identical, they are not patentably distinct from each other because the scope of the patented case wholly encompasses the scope of the current invention . Current Application U.S. Patent No. 11,195,270 1. A method for measuring and verifying drug portions, comprising : determining, by a verification device controller, individual key data for each of a plurality of drug portions included in a package based on a second digital image of the package from a calibrated verification camera arranged above the package and separate from the calibrated measuring camera and on a known calibration parameter of the calibrated verification camera ; receiving, by the verification device controller from a measuring camera controller, for each drug portion of the plurality of drug portions, compiled characteristic key data for a drug type compiled using a known calibration parameter of a calibrated measuring camera and a first digital image of an unpackaged drug portion of the drug type from the calibrated measuring camera disposed over a support surface upon which the unpackaged drug portion is arranged ; comparing, by the verification device controller, for each drug portion of the plurality of drug portions, the individual key data with characteristic key data of the drug type; and verifying or rejecting, by the verification device controller, the package based on a result of the comparing . 1. A method for measuring and verifying drug portions, comprising : generating at least one digital image of a drug portion of a drug type with a first calibrated camera of a measuring device, wherein the first calibrated camera is disposed over a support table upon which the drug portion to be measured is arranged ; transferring the generated digital image to a first control unit of the measuring device; compiling characteristic key data for the drug type by the first control unit of the measuring device using known calibration parameters of the first calibrated camera and of the digital image ; storing the characteristic key data of the drug type in a storage device; retrieving at least a portion of characteristic key data from or transmitting at least a portion of the characteristic key data to a verification device disposed separately from the measuring devic e; generating at least one digital image of the drug portion to be verified with a second calibrated camera of the verification device, wherein the second calibrated camera is fixedly arranged above a blister tube comprising a plurality of blister bags and separate from the first calibrated camera of the measuring device; transferring the generated digital image of the drug portion to be verified to a control unit of the verification device; determining individual key data for the drug portion to be verified by the control unit of the verification device based on known calibration parameters of the second calibrated camera and the at least one digital image ; and comparing, by the control unit of the verification device, the individual key data with characteristic key data of the corresponding drug type and, based on the results of the comparison, verifying or rejecting the drug portion , wherein drug portions to be measured and verified are disposed in one or more blister bags, wherein individual key data relating to the shape of the drug portions are reproduced by visually depicting the shape of the drug portions located in the one or more blister bags , and wherein during compilation the characteristic key data receive a time stamp and prior to the comparison of the characteristic key data with the individual key data of the drug portion to be verified, the verification device verifies the time stamp of the characteristic key data associated with the individual key data, and retrieves from the storage device and internally updates the characteristic key data, when a predetermined time difference is exceeded . 5. The method of claim 1, further comprising, during compilation of the characteristic key data, providing a time stamp by the measuring camera controller . 6. The method of claim 5, further comprising, prior to comparing the characteristic key data with the individual key data of each of the plurality of drug portions included in the package: verifying, by the verification device controller, the time stamp of the characteristic key data associated with the individual key data; and retrieving and updating, by the verification device controller, the characteristic key data from a storage device when a predetermined time difference is exceeded . 7. The method of claim 1, wherein the verifying or rejecting comprises: verifying or rejecting the package, by the verification device controller, based at least in part on the characteristic key data associated with respective drug types for each of the plurality of drug portions and on the individual key data generated using the second image of the package . 12. The method of claim 11 , further comprising: reproducing, by the verification device controller, individual key data relating to a shape of each of the drug portions by visually depicting the shape of the drug portions located in the one or more blister bags . 3. The method of claim 1, further comprising: retrieving the characteristic key data via a communication link in a storage device attached to a wide area network. 2. The method of claim 1, wherein the characteristic key data are stored via a communication link in the storage device configured as a cloud storage on the internet. 4. The method of claim 1, further comprising: transmitting, by the verification device controller, an authentication code; verifying, by a storage device, the authentication code; and one of: retrieving, by the verification device controller, the characteristic key data from the storage device only if the authentication code is valid; and transmitting the characteristic key data from the storage device to the verification device controller only if the authentication code is valid . 3. The method of claim 1, wherein the verification device transmits an authentication code, the storage device verifies the authentication code, and the characteristic key data are retrieved by the verification device only if the authentication code is valid. 4. The method of claim 1, wherein the verification device transmits an authentication code, the storage device verifies the authentication code, and the characteristic key data are transmitted to the verification device only if the authentication code is valid. 8. The method of claim 1, further comprising: obtaining, by an imaging device, a multiplicity of digital images of a calibration object having calibration characteristic data; and generating, by a controller of the imaging device, a calibration parameter for the imaging device based at least in part on key data for the calibration object and calibration data generated from the multiplicity of digital images, wherein the imaging device is one of the calibrated measuring camera or the calibrated verification camera, and wherein the controller is one of the measuring camera controller or the verification camera controller. 6. The method of claim 1, further comprising generating a calibration parameter for a camera by at least: generating, by the camera, a set of digital images of a multiplicity of calibration objects; and comparing at least one of the set of digital images with key data for the calibration objects in order to generate the calibration parameter. 9. The method of claim 1 , further comprising: positively verifying, by the verification device controller, the drug portion as being of the drug type if deviations from the comparing between the individual key data and the characteristic key data do not exceed specific predetermined threshold values. 10. The method of claim 1, wherein the drug portion is positively verified if deviations between the individual key data and the characteristic key data do not exceed specific predetermined threshold values. 10. The method of claim 1, further comprising: calibrating a measuring camera disposed at a distance from a support table; and positioning the calibrated measuring camera during use at the same distance from the support table as the measuring camera was positioned during calibration . 11. The method of claim 1, wherein the first calibrated camera of the measuring device during use is positioned at the same distance from the support table as the first calibrated camera was positioned during calibration. 11. The method of claim 1, wherein drug portions are disposed in one or more blister bags, wherein a plurality of blister bags are joined together in a blister tube, and the method further comprising: moving the blister tube under the calibrated measuring camera. 12. The method of claim 1, wherein a plurality of blister bags are joined together in a blister tube, and wherein the blister tube is moved from a first roll to a second roll past the first calibrated camera. 13 . A system for verifying drug portions, comprising : a plurality of blister systems, each blister system comprising: a calibrated verification camera; and a verification device in communication with the calibrated verification camera and a storage device, the verification device configured to : receive characteristic key data for each of a plurality of drugs based on images of the respective drugs, each image captured by a calibrated measuring camera disposed over a support surface upon which the respective drug is arranged and that is separate from the calibrated verification camera ; determine individual key data for each of the plurality of drugs included in a package based on a digital image of a package from a calibrated verification camera arranged above the package and separate from the calibrated measuring camera and on a known calibration parameter of the calibrated verification camera ; compare for each of the plurality of drugs, the individual key data with the characteristic key data for the drug; and verify or reject the package based on a result of the comparison . 13. A system for measuring and verifying drug portions, comprising: a measuring device; a storage device; and a verification device, wherein the system is configured to perform the method of claim 1 . 1. A method for measuring and verifying drug portions, comprising: generating at least one digital image of a drug portion of a drug type with a first calibrated camera of a measuring device, wherein the first calibrated camera is disposed over a support table upon which the drug portion to be measured is arranged ; transferring the generated digital image to a first control unit of the measuring device; compiling characteristic key data for the drug type by the first control unit of the measuring device using known calibration parameters of the first calibrated camera and of the digital image; storing the characteristic key data of the drug type in a storage device; retrieving at least a portion of characteristic key data from or transmitting at least a portion of the characteristic key data to a verification device disposed separately from the measuring device ; generating at least one digital image of the drug portion to be verified with a second calibrated camera of the verification device , wherein the second calibrated camera is fixedly arranged above a blister tube comprising a plurality of blister bags and separate from the first calibrated camera of the measuring device ; transferring the generated digital image of the drug portion to be verified to a control unit of the verification device; determining individual key data for the drug portion to be verified by the control unit of the verification device based on known calibration parameters of the second calibrated camera and the at least one digital image ; and comparing, by the control unit of the verification device, the individual key data with characteristic key data of the corresponding drug type and, based on the results of the comparison, verifying or rejecting the drug portion , wherein drug portions to be measured and verified are disposed in one or more blister bags, wherein individual key data relating to the shape of the drug portions are reproduced by visually depicting the shape of the drug portions located in the one or more blister bags, and wherein during compilation the characteristic key data receive a time stamp and prior to the comparison of the characteristic key data with the individual key data of the drug portion to be verified, the verification device verifies the time stamp of the characteristic key data associated with the individual key data, and retrieves from the storage device and internally updates the characteristic key data, when a predetermined time difference is exceeded. 15. The system of claim 13, wherein the verification device is configured to transmit an authentication code to receive the characteristic key data for each of the plurality of drugs; and wherein the storage device is configured to: determine that the authentication code is valid, and after determining that the authentication code is valid, provide, to the verification device, the characteristic key data. 3. The method of claim 1, wherein the verification device transmits an authentication code, the storage device verifies the authentication code, and the characteristic key data are retrieved by the verification device only if the authentication code is valid. 4. The method of claim 1, wherein the verification device transmits an authentication code, the storage device verifies the authentication code, and the characteristic key data are transmitted to the verification device only if the authentication code is valid. 17. A non-transitory computer-readable medium comprising instructions stored therein, which when executed by one or more processors, cause the processors to : generate, for each drug portion of a plurality of drug portions, a first digital image of a respective unpackaged drug portion of a drug type with a calibrated measuring camera disposed perpendicular to a support surface upon which the unpackaged drug portion is arranged ; compile characteristic key data for each drug type using a calibration parameter of the calibrated measuring camera and the first digital image of the respective unpackaged drug portion ; and generate a second digital image of a plurality of packaged drug portions with a calibrated verification camera arranged perpendicular to the plurality of packaged drug portions and separate from the calibrated measuring camera . 15. A non-transitory computer-readable medium comprising instructions stored therein, which when executed by a processor, cause the processor to compile characteristic key data of a drug type and to store said characteristic key data in a storage device by at least : generating at least one digital image of a drug portion of the drug type with a first calibrated camera of a measuring device, wherein the first calibrated camera is disposed over a support table upon which the drug portion to be measured is arranged ; transferring the generated digital image to a first control unit of the measuring device: compiling the characteristic key data for the drug type by the first control unit of the measuring device using known calibration parameters of the first calibrated camera and of the digital image; storing the characteristic key data of the drug type in a storage device; retrieving at least a portion of the characteristic key data from or transmitting at least a portion of the characteristic key data to a verification device disposed separately from the measuring device ; and generating, with a second calibrated camera of the verification device, at least one digital image of the drug portion to be verified, wherein the second calibrated camera is fixedly arranged above a blister tube comprising a plurality of blister bags and separate from the first calibrated camera of the measuring device , wherein drug portions to be measured and verified are disposed in one or more blister bags, wherein individual key data relating to the shape of the drug portions are reproduced by visually depicting the shape of the drug portions located in the one or more blister bags , and wherein during compilation of the characteristic key data, the instructions further cause the processor to receive a time stamp. 16. The non-transitory computer-readable medium of claim 15, further comprising instructions stored therein, which when executed by a processor, cause the processor to compile individual key data for a drug portion and to compare said individual key data with characteristic key data by at least : transferring the generated digital image of the drug portion to be verified to a control unit of the verification device ; determining individual key data for the drug portion to be verified by the control unit of the verification device based on known calibration parameters of the second calibrated camera and the digital image ; and comparing, by the control unit of the verification device, the individual key data with characteristic key data of the corresponding drug type and, based on the results of the comparison, verifying or rejecting the drug portion, wherein prior to the comparison of the characteristic key data with the individual key data of the drug portion to be verified , the instructions cause the verification device to verify the time stamp of the characteristic key data associated with the individual key data, and to retrieve from the storage device and internally updates the characteristic key data, when a predetermined time difference is exceeded. 18. The non-transitory computer-readable medium of claim 17, further comprising instructions stored therein, which when executed by the one or more processors, cause the processors to: generate individual key data for each of the plurality of packaged drug portions based on a calibration parameter of the calibrated verification camera and the second digital image of the plurality of packaged drug portions, and generate, for each of the plurality of drug portions, a verification output indicating whether the packaged drug portion is the drug type based at least in part on a comparison between the characteristic key data for the drug type and the individual key data . 19. The non-transitory computer-readable medium of claim 17 , further comprising instructions stored therein, which when executed by the one or more processors, cause the processors to: retrieve at least a portion of the characteristic key data from or transmit at least a portion of the characteristic key data to a verification device disposed separately from the measuring camera; and receive at or transmit to a verification controller, an expected drug type for each packaged drug portion, and wherein the characteristic key data retrieved or transmitted corresponds to the expected drug type . 08-34 AIA Claim s 1, 3 – 15 and 17 – 20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim s 1- 15 and 17 - 20 of U.S. Patent No. 11,664, 117 . Although the claims at issue are not identical, they are not patentably distinct from each other because the scope of the patented case wholly encompasses the scope of the current invention . Current Application U.S. Patent No. 11,664, 117 1. A method for measuring and verifying drug portions, comprising : determining, by a verification device controller, individual key data for each of a plurality of drug portions included in a package based on a second digital image of the package from a calibrated verification camera arranged above the package and separate from the calibrated measuring camera and on a known calibration parameter of the calibrated verification camera ; receiving, by the verification device controller from a measuring camera controller, for each drug portion of the plurality of drug portions, compiled characteristic key data for a drug type compiled using a known calibration parameter of a calibrated measuring camera and a first digital image of an unpackaged drug portion of the drug type from the calibrated measuring camera disposed over a support surface upon which the unpackaged drug portion is arranged ; comparing, by the verification device controller, for each drug portion of the plurality of drug portions, the individual key data with characteristic key data of the drug type; and verifying or rejecting, by the verification device controller, the package based on a result of the comparing . 1dd. A method for measuring and verifying drug portions, comprising: receiving, by a verification device controller from a measuring camera controller, at least a portion of compiled characteristic key data for a drug type compiled using at least: (i) a known calibration parameter of a calibrated measuring camera and (ii) a first digital image of an unpackaged drug portion of the drug type from the calibrated measuring camera disposed over a support surface upon which the unpackaged drug portion is arranged ; receiving, by the verification device controller, a second digital image of a package including a drug portion from a calibrated verification camera arranged above the package and separate from the calibrated measuring camera ; determining, by the verification device controller, individual key data for the drug portion included in the package based at least on: (i) a known calibration parameter of the calibrated verification camera and (ii) the second digital image of the package including the drug portion ; comparing, by the verification device controller, the individual key data with characteristic key data of the drug typ e; and verifying or rejecting, by the verification device controller, the package including the drug portion as being of the drug type based on a result of the comparing . 7. The method of claim 1, wherein the package includes multiple drug portions, and wherein said verifying or rejecting comprises: verifying or rejecting the package, by the verification device controller, based at least in part on the characteristic key data associated with respective drug types for each of the multiple drug portions and on the individual key data generated using the second image of the package . 3. The method of claim 1, further comprising: retrieving the characteristic key data via a communication link in a storage device attached to a wide area network. 2. The method of claim 1, further comprising: storing the characteristic key data via a communication link in a storage device attached to a wide area network . 4. The method of claim 1, further comprising: transmitting, by the verification device controller, an authentication code; verifying, by a storage device, the authentication code; and one of: retrieving, by the verification device controller, the characteristic key data from the storage device only if the authentication code is valid; and transmitting the characteristic key data from the storage device to the verification device controller only if the authentication code is valid . 3. The method of claim 1, further comprising: transmitting, by the verification device controller, an authentication code; verifying, by a storage device, the authentication code; and retrieving, by the verification device controller, the characteristic key data from the storage device only if the authentication code is valid . 4. The method of claim 1, further comprising: transmitting, by the verification device controller, an authentication code; verifying, by a storage device, the authentication code; and transmitting the characteristic key data from the storage device to the verification device controller only if the authentication code is valid . 5. The method of claim 1, further comprising, during compilation of the characteristic key data, providing a time stamp by the measuring camera controller . 5. The method of claim 1, further comprising, during compilation of the characteristic key data, providing a time stamp by the measuring camera controller . 6. The method of claim 5, further comprising, prior to comparing the characteristic key data with the individual key data of each of the plurality of drug portions included in the package: verifying, by the verification device controller, the time stamp of the characteristic key data associated with the individual key data; and retrieving and updating, by the verification device controller, the characteristic key data from a storage device when a predetermined time difference is exceeded . 6. The method of claim 5, further comprising, prior to comparing the characteristic key data with the individual key data of the drug portion included in the package: verifying, by the verification device controller, the time stamp of the characteristic key data associated with the individual key data; and retrieving and updating, by the verification device controller, the characteristic key data from a storage device when a predetermined time difference is exceeded . 7. The method of claim 1, wherein the verifying or rejecting comprises: verifying or rejecting the package, by the verification device controller, based at least in part on the characteristic key data associated with respective drug types for each of the plurality of drug portions and on the individual key data generated using the second image of the package . 7. The method of claim 1 , wherein the package includes multiple drug portions, and wherein said verifying or rejecting comprises: verifying or rejecting the package, by the verification device controller, based at least in part on the characteristic key data associated with respective drug types for each of the multiple drug portions and on the individual key data generated using the second image of the package . 8. The method of claim 1, further comprising: obtaining, by an imaging device, a multiplicity of digital images of a calibration object having calibration characteristic data; and generating, by a controller of the imaging device, a calibration parameter for the imaging device based at least in part on key data for the calibration object and calibration data generated from the multiplicity of digital images, wherein the imaging device is one of the calibrated measuring camera or the calibrated verification camera, and wherein the controller is one of the measuring camera controller or the verification camera controller. 8. The method of claim 1, further comprising: obtaining, by an imaging device, a multiplicity of digital images of a calibration object having calibration characteristic data; and generating, by a controller of the imaging device, a calibration parameter for the imaging device based at least in part on key data for the calibration object and calibration data generated from the multiplicity of digital images, wherein the imaging device is one of the calibrated measuring camera or the calibrated verification camera, and wherein the controller is one of the measuring camera controller or the verification camera controller . 9. The method of claim 1 , further comprising: positively verifying, by the verification device controller, the drug portion as being of the drug type if deviations from the comparing between the individual key data and the characteristic key data do not exceed specific predetermined threshold values. 9. The method of claim 1, further comprising: positively verifying, by the verification device controller, the drug portion as being of the drug type if deviations from the comparing between the individual key data and the characteristic key data do not exceed specific predetermined threshold values . 10. The method of claim 1, further comprising: calibrating a measuring camera disposed at a distance from a support table; and positioning the calibrated measuring camera during use at the same distance from the support table as the measuring camera was positioned during calibration . 10. The method of claim 1, further comprising: calibrating a measuring camera disposed at a distance from a support table; and positioning the calibrated measuring camera during use at the same distance from the support table as the measuring camera was positioned during calibration 11. The method of claim 1, wherein drug portions are disposed in one or more blister bags, wherein a plurality of blister bags are joined together in a blister tube, and the method further comprising: moving the blister tube under the calibrated measuring camera. 11. The method of claim 1, wherein drug portions are disposed in one or more blister bags, wherein a plurality of blister bags are joined together in a blister tube, and the method further comprising: moving the blister tube under the calibrated measuring camera from a first roll to a second roll . 12. The method of claim 11 , further comprising: reproducing, by the verification device controller, individual key data relating to a shape of each of the drug portions by visually depicting the shape of the drug portions located in the one or more blister bags . 12. The method of claim 11, further comprising: reproducing, by the verification device controller, individual key data relating to the shape of the drug portions by visually depicting the shape of the drug portions located in the one or more blister bags 13 . A system for verifying drug portions, comprising : a plurality of blister systems, each blister system comprising: a calibrated verification camera; and a verification device in communication with the calibrated verification camera and a storage device, the verification device configured to : receive characteristic key data for each of a plurality of drugs based on images of the respective drugs, each image captured by a calibrated measuring camera disposed over a support surface upon which the respective drug is arranged and that is separate from the calibrated verification camera ; determine individual key data for each of the plurality of drugs included in a package based on a digital image of a package from a calibrated verification camera arranged above the package and separate from the calibrated measuring camera and on a known calibration parameter of the calibrated verification camera ; compare for each of the plurality of drugs, the individual key data with the characteristic key data for the drug; and verify or reject the package based on a result of the comparison . 13. A system for measuring and verifying drug portions, comprising : a measuring device in communication with a first calibrated camera disposed above a support surface, the measuring device configured to: receive , from the first calibrated camera, a first digital image of an unpackaged drug portion of a drug type on the support surface, and compile characteristic key data for the drug type using at least: (i) a first calibration parameter of the first calibrated camera and (ii) the first digital image of the unpackaged drug portion ; and a verification device having a storage device and in communication with a second calibrated camera , wherein the verification device is separate from the measuring device , and wherein the second calibrated camera is separate from the first calibrated camera , and wherein the verification device is configured to: receive at least a portion of the characteristic key data from the measuring device , store the at least a portion of the characteristic key data in the storage device, receive, from the second calibrated camera, a second digital image of a packaged drug portion, generate individual key data for the packaged drug portion based at least on: (i) a second calibration parameter of the second calibrated camera and (ii) the second digital image of the packaged drug portion , and generate a verification output indicating whether the packaged drug portion is the drug type based at least in part on a comparison between the characteristic key data for the drug type and the individual key data . 14. The system of claim 13 , wherein the plurality of drugs are enclosed within a blister bag included in a blister tube of joined blister bags, wherein the blister tube is arranged to pass within a field of view of the calibrated verification camera, wherein the system includes a first roll and a second roll, and wherein at least one of the first roll and the second roll rotate in response to an output of the verification camera . 14. The system of claim 13, wherein the packaged drug portion is enclosed within a blister bag included in a blister tube of joined blister bags, wherein the blister tube is arranged to pass within a field of view of the second calibrated camera, wherein the system includes a first roll and a second roll, and wherein at least one of the first roll and the second roll rotate in response to the verification output. 15. The system of claim 13, wherein the verification device is configured to transmit an authentication code to receive the characteristic key data for each of the plurality of drugs; and wherein the storage device is configured to: determine that the authentication code is valid, and after determining that the authentication code is valid, provide, to the verification device, the characteristic key data. 15. The system of claim 13, wherein the verification device is configured to transmit an authentication code to retrieve the characteristic key data for the drug type; and wherein the storage device is configured to: determine that the authentication code is valid, and after determining that the authentication code is valid, provide, to the verification device, the characteristic key data . 17. A non-transitory computer-readable medium comprising instructions stored therein, which when executed by one or more processors, cause the processors to : generate, for each drug portion of a plurality of drug portions, a first digital image of a respective unpackaged drug portion of a drug type with a calibrated measuring camera disposed perpendicular to a support surface upon which the unpackaged drug portion is arranged ; compile characteristic key data for each drug type using a calibration parameter of the calibrated measuring camera and the first digital image of the respective unpackaged drug portion ; and generate a second digital image of a plurality of packaged drug portions with a calibrated verification camera arranged perpendicular to the plurality of packaged drug portions and separate from the calibrated measuring camera . 17. A non-transitory computer-readable medium comprising instructions stored therein, which when executed by one or more processors, cause the processors to: generate a first digital image of an unpackaged drug portion of a drug type with a calibrated measuring camera disposed perpendicular to a support surface upon which the unpackaged drug portion is arranged ; compile characteristic key data for the drug type using at least: (i) a first calibration parameter of the calibrated measuring camera and (ii) the first digital image of the unpackaged drug portion retrieve at least a portion of the characteristic key data from or transmit at least a portion of the characteristic key data to a verification device disposed separately from the measuring camera ; and generate a second digital image of a packaged drug portion with a calibrated verification camera arranged perpendicular to the packaged drug portion and separate from the calibrated measuring camera . 18. The non-transitory computer-readable medium of claim 17, further comprising instructions stored therein, which when executed by the one or more processors, cause the processors to: generate individual key data for each of the plurality of packaged drug portions based on a calibration parameter of the calibrated verification camera and the second digital image of the plurality of packaged drug portions, and generate, for each of the plurality of drug portions, a verification output indicating whether the packaged drug portion is the drug type based at least in part on a comparison between the characteristic key data for the drug type and the individual key data . 18. The non-transitory computer-readable medium of claim 17, further comprising instructions stored therein, which when executed by the one or more processors, cause the processors to: generate individual key data for the packaged drug portion based at least on: (i) a second calibration parameter of a calibrated verification camera and (ii) the second digital image of the packaged drug portion, and generate a verification output indicating whether the packaged drug portion is the drug type based at least in part on a comparison between the characteristic key data for the drug type and the individual key data. 19. The non-transitory computer-readable medium of claim 17 , further comprising instructions stored therein, which when executed by the one or more processors, cause the processors to: retrieve at least a portion of the characteristic key data from or transmit at least a portion of the characteristic key data to a verification device disposed separately from the measuring camera; and receive at or transmit to a verification controller, an expected drug type for each packaged drug portion, and wherein the characteristic key data retrieved or transmitted corresponds to the expected drug type. 19. The non-transitory computer-readable medium of claim 17, further comprising instructions stored therein, which when executed by the one or more processors, cause the processors to: receive at or transmit to a verification controller, an expected drug type for the packaged drug portion, and wherein the characteristic key data retrieved or transmitted corresponds to the expected drug type. 20. The non-transitory computer-readable medium of claim 17, wherein the characteristic key data comprises a range for a characteristic of each drug type, wherein the instructions stored therein, which when executed by the one or more processors, cause the processors to generate the range based on a plurality of digital images of the drug type and the calibration parameter . 20. The non-transitory computer-readable medium of claim 17, wherein the characteristic key data comprises a range for a characteristic of the drug type, wherein the instructions stored therein, which when executed by the one or more processors, cause the processors to generate the range based on a plurality of digital images of the drug type and the calibration parameter . 08-34 AIA Claim s 1 and 3 – 15 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim s 1 - 15 of U.S. Patent No. 12,394,513 . Although the claims at issue are not identical, they are not patentably distinct from each other because the scope of the patented case wholly encompasses the scope of the current invention . Current Application U.S. Patent No. 12,394,513 1. A method for measuring and verifying drug portions, comprising : determining, by a verification device controller, individual key data for each of a plurality of drug portions included in a package based on a second digital image of the package from a calibrated verification camera arranged above the package and separate from the calibrated measuring camera and on a known calibration parameter of the calibrated verification camera ; receiving, by the verification device controller from a measuring camera controller, for each drug portion of the plurality of drug portions, compiled characteristic key data for a drug type compiled using a known calibration parameter of a calibrated measuring camera and a first digital image of an unpackaged drug portion of the drug type from the calibrated measuring camera disposed over a support surface upon which the unpackaged drug portion is arranged ; comparing, by the verification device controller, for each drug portion of the plurality of drug portions, the individual key data with characteristic key data of the drug type; and verifying or rejecting, by the verification device controller, the package based on a result of the comparing . 1. A method for verifying drug portions, comprising : receiving, by a first verification device and a second verification device, characteristic key data for a drug, the characteristic key data based on images for the drug captured by a calibrated measuring camera disposed over a support surface upon which the drug is arranged ; receiving a package including a drug portion of the drug, the package including an identifier for the drug portion included in the package; receiving, by the first verification device and the second verification device, a digital image of the package from a calibrated verification camera arranged above the package and that is separate from the calibrated measuring camera ; determining, by each of the first verification device and the second verification device, individual key data for the drug portion included in the package based at least on a known calibration parameter of the calibrated verification camera and the digital image of the package including the drug portion ; comparing, by each of the first verification device and the second verification device, the individual key data with the characteristic key data for the drug; and verifying or rejecting, by each of the first verification device and the second verification device, the package including the drug portion corresponding to the drug based on a result of the comparing . 3. The method of claim 1, further comprising: retrieving the characteristic key data via a communication link in a storage device attached to a wide area network. 2. The method of claim 1, further comprising: retrieving the characteristic key data via a communication interface of a storage device attached to a wide area network. 4. The method of claim 1, further comprising: transmitting, by the verification device controller, an authentication code; verifying, by a storage device, the authentication code; and one of: retrieving, by the verification device controller, the characteristic key data from the storage device only if the authentication code is valid; and transmitting the characteristic key data from the storage device to the verification device controller only if the authentication code is valid . . The method of claim 1, further comprising: transmitting, by one of the first verification device and the second verification device, an authentication code to retrieve the characteristic key data for the drug type; verifying, by a storage device, the authentication code; and retrieving, by the one of the first verification device and the second verification device, the characteristic key data from the storage device only if the authentication code is valid . 4. The method of claim 1, further comprising: transmitting , by one of the first verification device and the second verification device, an authentication code to retrieve the characteristic key data for the drug type; causing, by the one of the first verification device and the second verification device, verification of the authentication code by a storage device; and causing, by the one of the first verification device and the second verification device, providing of the characteristic key data by the storage device to the one of the first verification device and the second verification device after determining the authentication code is valid . 5. The method of claim 1, further comprising, during compilation of the characteristic key data, providing a time stamp by the measuring camera controller . 5. The method of claim 1 , further comprising, during compilation of the characteristic key data, providing a time stamp. 6. The method of claim 5, further comprising, prior to comparing the characteristic key data with the individual key data of each of the plurality of drug portions included in the package: verifying, by the verification device controller, the time stamp of the characteristic key data associated with the individual key data; and retrieving and updating, by the verification device controller, the characteristic key data from a storage device when a predetermined time difference is exceeded . 6. The method of claim 5, further comprising, prior to comparing the characteristic key data with the individual key data of the drug portion included in the package: verifying, by one of the first verification device and the second verification device, the time stamp of the characteristic key data associated with the individual key data; and retrieving and updating, by the one of the first verification device and the second verification device, the characteristic key data from a storage device when a predetermined time difference is exceeded. 7. The method of claim 1, wherein the verifying or rejecting comprises: verifying or rejecting the package, by the verification device controller, based at least in part on the characteristic key data associated with respective drug types for each of the plurality of drug portions and on the individual key data generated using the second image of the package . 7. The method of claim 1, wherein the package includes multiple drug portions, and wherein said verifying or rejecting comprises: verifying or rejecting the package, by one of the first verification device and the second verification device, based at least in part on the characteristic key data associated with respective drug types for each of the multiple drug portions and on the individual key data generated using a second image of the package . 8. The method of claim 1, further comprising: obtaining, by an imaging device, a multiplicity of digital images of a calibration object having calibration characteristic data; and generating, by a controller of the imaging device, a calibration parameter for the imaging device based at least in part on key data for the calibration object and calibration data generated from the multiplicity of digital images, wherein the imaging device is one of the calibrated measuring camera or the calibrated verification camera, and wherein the controller is one of the measuring camera controller or the verification camera controller. 8. The method of claim 1, further comprising: obtaining, by an imaging device, a multiplicity of digital images of a calibration object having calibration characteristic data; and generating, by a controller of the imaging device, a calibration parameter for the imaging device based at least in part on key data for the calibration object and calibration data generated from the multiplicity of digital images, wherein the imaging device is one of the calibrated measuring camera or the calibrated verification camera, and wherein the controller is one of a measuring camera controller or a verification camera controller. 9. The method of claim 1 , further comprising: positively verifying, by the verification device controller, the drug portion as being of the drug type if deviations from the comparing between the individual key data and the characteristic key data do not exceed specific predetermined threshold values. 9. The method of claim 1, further comprising: positively verifying, by one of the first verification device and the second verification device, the drug portion as being of the drug type if deviations from the comparing between the individual key data and the characteristic key data do not exceed specific predetermined threshold values. 10. The method of claim 1, further comprising: calibrating a measuring camera disposed at a distance from a support table; and positioning the calibrated measuring camera during use at the same distance from the support table as the measuring camera was positioned during calibration . 10. The method of claim 1, further comprising: wherein calibrating a camera comprises disposing the camera at a distance from a support table; and positioning the calibrated camera during use at the same distance from the support table as the camera was positioned during calibration. 11. The method of claim 1, wherein drug portions are disposed in one or more blister bags, wherein a plurality of blister bags are joined together in a blister tube, and the method further comprising: moving the blister tube under the calibrated measuring camera. 11. The method of claim 1, wherein drug portions are disposed in one or more blister bags, wherein a plurality of blister bags are joined together in a blister tube, and the method further comprising: moving the blister tube under the calibrated verification camera from a first roll to a second roll. 12. The method of claim 11 , further comprising: reproducing, by the verification device controller, individual key data relating to a shape of each of the drug portions by visually depicting the shape of the drug portions located in the one or more blister bags . 12. The method of claim 11, further comprising: reproducing, by one of the first verification device and the second verification device, individual key data relating to a shape of the drug portions by visually depicting the shape of the drug portions located in the one or more blister bags. 13 . A system for verifying drug portions, comprising : a plurality of blister systems, each blister system comprising: a calibrated verification camera; and a verification device in communication with the calibrated verification camera and a storage device, the verification device configured to : receive characteristic key data for each of a plurality of drugs based on images of the respective drugs, each image captured by a calibrated measuring camera disposed over a support surface upon which the respective drug is arranged and that is separate from the calibrated verification camera ; determine individual key data for each of the plurality of drugs included in a package based on a digital image of a package from a calibrated verification camera arranged above the package and separate from the calibrated measuring camera and on a known calibration parameter of the calibrated verification camera ; compare for each of the plurality of drugs, the individual key data with the characteristic key data for the drug; and verify or reject the package based on a result of the comparison . 13. A system for verifying drug portions, comprising: a calibrated verification camera; and a plurality of verification devices in communication with the calibrated verification camera and a storage device, each of the plurality of verification devices configured to : receive characteristic key data for a drug based on images of the drug captured by a calibrated measuring camera disposed over a support surface upon which the drug is arranged and that is separate from the calibrated verification camera ; receive, from the calibrated verification camera, a digital image of a package including a drug portion of the drug, the calibrated verification camera arranged above the package; determine individual key data for the drug portion included in the package based at least on a known calibration parameter of the calibrated verification camera and the digital image of the package including the drug portion ; compare the individual key data with the characteristic key data for the drug; and verify or reject the package including the drug portion corresponding to the drug based on a result of the comparison. 14. The system of claim 13 , wherein the plurality of drugs are enclosed within a blister bag included in a blister tube of joined blister bags, wherein the blister tube is arranged to pass within a field of view of the calibrated verification camera, wherein the system includes a first roll and a second roll, and wherein at least one of the first roll and the second roll rotate in response to an output of the verification camera . 14. The system of claim 13, wherein the packaged drug portion is enclosed within a blister bag included in a blister tube of joined blister bags, wherein the blister tube is arranged to pass within a field of view of the calibrated verification camera, wherein the system includes a first roll and a second roll, and wherein at least one of the first roll and the second roll rotate in response to the verification or rejection of the blister bag. 15. The system of claim 13, wherein the verification device is configured to transmit an authentication code to receive the characteristic key data for each of the plurality of drugs; and wherein the storage device is configured to: determine that the authentication code is valid, and after determining that the authentication code is valid, provide, to the verification device, the characteristic key data. 15. The system of claim 13, wherein a first verification device of the plurality of verification devices is configured to transmit an authentication code to retrieve the characteristic key data for the drug type; and wherein the first verification device is configured to cause the storage device to: determine that the authentication code is valid; and after determining that the authentication code is valid, provide, to the first verification device, the characteristic key data. Allowable Subject Matter Claim 16 is objected to as being dependent upon a rejected base claim. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHANIKA M BRUMFIELD whose telephone number is (571)270-3700. The examiner can normally be reached M-F 8:30 - 5 PM AWS. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Czekaj can be reached at 571-272-7327. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. SHANIKA M. BRUMFIELD Examiner Art Unit 2487 /SHANIKA M BRUMFIELD/Examiner, Art Unit 2487 /Dave Czekaj/Supervisory Patent Examiner, Art Unit 2487 Application/Control Number: 19/268,875 Page 2 Art Unit: 2487 Application/Control Number: 19/268,875 Page 3 Art Unit: 2487 Application/Control Number: 19/268,875 Page 4 Art Unit: 2487 Application/Control Number: 19/268,875 Page 5 Art Unit: 2487 Application/Control Number: 19/268,875 Page 6 Art Unit: 2487 Application/Control Number: 19/268,875 Page 7 Art Unit: 2487 Application/Control Number: 19/268,875 Page 8 Art Unit: 2487 Application/Control Number: 19/268,875 Page 9 Art Unit: 2487 Application/Control Number: 19/268,875 Page 10 Art Unit: 2487 Application/Control Number: 19/268,875 Page 11 Art Unit: 2487 Application/Control Number: 19/268,875 Page 12 Art Unit: 2487 Application/Control Number: 19/268,875 Page 13 Art Unit: 2487 Application/Control Number: 19/268,875 Page 14 Art Unit: 2487 Application/Control Number: 19/268,875 Page 15 Art Unit: 2487 Application/Control Number: 19/268,875 Page 16 Art Unit: 2487 Application/Control Number: 19/268,875 Page 17 Art Unit: 2487 Application/Control Number: 19/268,875 Page 18 Art Unit: 2487 Application/Control Number: 19/268,875 Page 19 Art Unit: 2487 Application/Control Number: 19/268,875 Page 20 Art Unit: 2487 Application/Control Number: 19/268,875 Page 21 Art Unit: 2487 Application/Control Number: 19/268,875 Page 22 Art Unit: 2487 Application/Control Number: 19/268,875 Page 23 Art Unit: 2487 Application/Control Number: 19/268,875 Page 24 Art Unit: 2487 Application/Control Number: 19/268,875 Page 25 Art Unit: 2487 Application/Control Number: 19/268,875 Page 26 Art Unit: 2487 Application/Control Number: 19/268,875 Page 27 Art Unit: 2487 Application/Control Number: 19/268,875 Page 28 Art Unit: 2487 Application/Control Number: 19/268,875 Page 29 Art Unit: 2487 Application/Control Number: 19/268,875 Page 30 Art Unit: 2487 Application/Control Number: 19/268,875 Page 31 Art Unit: 2487 Application/Control Number: 19/268,875 Page 32 Art Unit: 2487 Application/Control Number: 19/268,875 Page 33 Art Unit: 2487 Application/Control Number: 19/268,875 Page 34 Art Unit: 2487 Application/Control Number: 19/268,875 Page 35 Art Unit: 2487 Application/Control Number: 19/268,875 Page 36 Art Unit: 2487 Application/Control Number: 19/268,875 Page 37 Art Unit: 2487 Application/Control Number: 19/268,875 Page 38 Art Unit: 2487 Application/Control Number: 19/268,875 Page 39 Art Unit: 2487 Application/Control Number: 19/268,875 Page 40 Art Unit: 2487 Application/Control Number: 19/268,875 Page 41 Art Unit: 2487 Application/Control Number: 19/268,875 Page 42 Art Unit: 2487 Application/Control Number: 19/268,875 Page 43 Art Unit: 2487 Application/Control Number: 19/268,875 Page 44 Art Unit: 2487 Application/Control Number: 19/268,875 Page 45 Art Unit: 2487 Application/Control Number: 19/268,875 Page 46 Art Unit: 2487 Application/Control Number: 19/268,875 Page 47 Art Unit: 2487 Application/Control Number: 19/268,875 Page 48 Art Unit: 2487 Application/Control Number: 19/268,875 Page 49 Art Unit: 2487 Application/Control Number: 19/268,875 Page 50 Art Unit: 2487 Application/Control Number: 19/268,875 Page 51 Art Unit: 2487 Application/Control Number: 19/268,875 Page 52 Art Unit: 2487 Application/Control Number: 19/268,875 Page 53 Art Unit: 2487 Application/Control Number: 19/268,875 Page 54 Art Unit: 2487 Application/Control Number: 19/268,875 Page 55 Art Unit: 2487 Application/Control Number: 19/268,875 Page 56 Art Unit: 2487 Application/Control Number: 19/268,875 Page 57 Art Unit: 2487 Application/Control Number: 19/268,875 Page 58 Art Unit: 2487 Application/Control Number: 19/268,875 Page 59 Art Unit: 2487 Application/Control Number: 19/268,875 Page 60 Art Unit: 2487 Application/Control Number: 19/268,875 Page 61 Art Unit: 2487 Application/Control Number: 19/268,875 Page 62 Art Unit: 2487 Application/Control Number: 19/268,875 Page 63 Art Unit: 2487 Application/Control Number: 19/268,875 Page 64 Art Unit: 2487 Application/Control Number: 19/268,875 Page 65 Art Unit: 2487 Application/Control Number: 19/268,875 Page 66 Art Unit: 2487 Application/Control Number: 19/268,875 Page 67 Art Unit: 2487 Application/Control Number: 19/268,875 Page 68 Art Unit: 2487 Application/Control Number: 19/268,875 Page 69 Art Unit: 2487 Application/Control Number: 19/268,875 Page 70 Art Unit: 2487 Application/Control Number: 19/268,875 Page 71 Art Unit: 2487 Application/Control Number: 19/268,875 Page 72 Art Unit: 2487 Application/Control Number: 19/268,875 Page 73 Art Unit: 2487 Application/Control Number: 19/268,875 Page 74 Art Unit: 2487 Application/Control Number: 19/268,875 Page 75 Art Unit: 2487 Application/Control Number: 19/268,875 Page 76 Art Unit: 2487 Application/Control Number: 19/268,875 Page 77 Art Unit: 2487 Application/Control Number: 19/268,875 Page 78 Art Unit: 2487 Application/Control Number: 19/268,875 Page 79 Art Unit: 2487 Application/Control Number: 19/268,875 Page 80 Art Unit: 2487 Application/Control Number: 19/268,875 Page 81 Art Unit: 2487 Application/Control Number: 19/268,875 Page 82 Art Unit: 2487 Application/Control Number: 19/268,875 Page 83 Art Unit: 2487 Application/Control Number: 19/268,875 Page 84 Art Unit: 2487 Application/Control Number: 19/268,875 Page 85 Art Unit: 2487 Application/Control Number: 19/268,875 Page 86 Art Unit: 2487 Application/Control Number: 19/268,875 Page 87 Art Unit: 2487 Application/Control Number: 19/268,875 Page 88 Art Unit: 2487 Application/Control Number: 19/268,875 Page 89 Art Unit: 2487 Application/Control Number: 19/268,875 Page 90 Art Unit: 2487 Application/Control Number: 19/268,875 Page 91 Art Unit: 2487 Application/Control Number: 19/268,875 Page 92 Art Unit: 2487 Application/Control Number: 19/268,875 Page 93 Art Unit: 2487 Application/Control Number: 19/268,875 Page 94 Art Unit: 2487 Application/Control Number: 19/268,875 Page 95 Art Unit: 2487 Application/Control Number: 19/268,875 Page 96 Art Unit: 2487 Application/Control Number: 19/268,875 Page 97 Art Unit: 2487 Application/Control Number: 19/268,875 Page 98 Art Unit: 2487 Application/Control Number: 19/268,875 Page 99 Art Unit: 2487 Application/Control Number: 19/268,875 Page 100 Art Unit: 2487 Application/Control Number: 19/268,875 Page 101 Art Unit: 2487 Application/Control Number: 19/268,875 Page 102 Art Unit: 2487 Application/Control Number: 19/268,875 Page 103 Art Unit: 2487 Application/Control Number: 19/268,875 Page 104 Art Unit: 2487 Application/Control Number: 19/268,875 Page 105 Art Unit: 2487 Application/Control Number: 19/268,875 Page 106 Art Unit: 2487 Application/Control Number: 19/268,875 Page 107 Art Unit: 2487 Application/Control Number: 19/268,875 Page 108 Art Unit: 2487 Application/Control Number: 19/268,875 Page 109 Art Unit: 2487
Read full office action

Prosecution Timeline

Jul 14, 2025
Application Filed
Jun 18, 2026
Non-Final Rejection mailed — §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12684101
ACTIVE DUAL PIXEL STEREO SYSTEM FOR DEPTH EXTRACTION
4y 7m to grant Granted Jul 14, 2026
Patent 12684119
Systems and Methods for Luma or Chroma Statistics Collection
4y 5m to grant Granted Jul 14, 2026
Patent 12684115
SYSTEMS AND METHODS FOR CONSTRUCTING INTRA MODE LISTS
2y 10m to grant Granted Jul 14, 2026
Patent 12677008
MULTI-FEATURE SAMPLE OFFSET FILTERING SYSTEM FOR VIDEO CODING AND DECODING
3y 8m to grant Granted Jul 07, 2026
Patent 12666017
ENCODER, DECODER, ENCODING METHOD, AND DECODING METHOD
1y 9m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
83%
With Interview (+14.3%)
2y 9m (~1y 9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 393 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month